Page last updated: 2024-10-16

carnitine and Daytime Sleepiness

carnitine has been researched along with Daytime Sleepiness in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Blood samples from 57 NT1, 51 other hypersomnia patients, and 61 healthy controls were analyzed."5.72Low carnitine palmitoyltransferase 1 activity is a risk factor for narcolepsy type 1 and other hypersomnia. ( Honda, M; Honda, Y; Miyagawa, T; Shigematsu, Y; Shimada, M; Tokunaga, K, 2022)
"Blood samples from 57 NT1, 51 other hypersomnia patients, and 61 healthy controls were analyzed."1.72Low carnitine palmitoyltransferase 1 activity is a risk factor for narcolepsy type 1 and other hypersomnia. ( Honda, M; Honda, Y; Miyagawa, T; Shigematsu, Y; Shimada, M; Tokunaga, K, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Honda, M1
Shigematsu, Y1
Shimada, M1
Honda, Y1
Tokunaga, K1
Miyagawa, T1
Ko, JM1
Shin, CH1
Yang, SW1
Seong, MW1
Park, SS1
Song, J1

Other Studies

2 other studies available for carnitine and Daytime Sleepiness

ArticleYear
Low carnitine palmitoyltransferase 1 activity is a risk factor for narcolepsy type 1 and other hypersomnia.
    Sleep, 2022, 10-10, Volume: 45, Issue:10

    Topics: Carnitine; Carnitine Acyltransferases; Carnitine O-Palmitoyltransferase; Disorders of Excessive Somn

2022
The first Korean case of lysinuric protein intolerance: presented with short stature and increased somnolence.
    Journal of Korean medical science, 2012, Volume: 27, Issue:8

    Topics: Amino Acid Metabolism, Inborn Errors; Amino Acid Transport System y+L; Antifungal Agents; Asian Peop

2012